Brevan Howard Capital Management LP Travere Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 61,695 shares of TVTX stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
61,695
Previous 61,295
0.65%
Holding current value
$1.26 Million
Previous $503,000
71.57%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TVTX
# of Institutions
196Shares Held
84.9MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$156 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$156 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$141 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$95.8 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$88.8 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.31B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...